Research
Hormonal
Subcutaneous semaglutide 0.5 mg and subcutaneous liraglutide 3 mg are effective treatments for reducing weight among people with obesity in a real-world scenario after 3 months.
Both semaglutide and liraglutide can be considered effective options for weight management in clinical practice.
StrongSupportsmedium confidence
subcutaneous semaglutide 0.5 mg and subcutaneous liraglutide 3 mg are effective treatments for reducing weight safely among PwO in a real-world scenario at short term.
Why this rating
The study involves a retrospective evaluation of a significant number of participants.
Source
The GLP-1 analogue battle: effects of semaglutide 0,5 mg/weekly versus liraglutide 3 mg/daily on anthropometric parameters after 3 months in a real world-scenario
Joana Nicolau et al. · Nutrición Hospitalaria · 2024
cohort · n=179Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →